5 Biotech Stocks to Watch With the Coronavirus Scare [The Motley Fool]
BioCryst Pharmaceuticals, Inc. (BCRX)
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
biocryst.gcs-web.com/investor-relations
Company Research
Source: The Motley Fool
This week's headlines almost sound like the plot of a thriller movie. A Chinese city that's home to million people is locked down, with no one allowed to enter or leave after a deadly virus infects hundreds and kills at least people. Worries intensify after the virus spreads across the Pacific to the United States. Government authorities brace for the possibility of a pandemic that could sweep across the world. Unfortunately, none of those things were taken from a movie plot. They're reality instead of fiction. The coronavirus that has affected China and now the U.S. is stirring up concerns about what could be next. And many investors are looking to the drugmakers that could potentially step in to help alleviate those concerns. Here are five biotech stocks Image source: Getty Images. . Biocryst Pharmaceuticals ( NASDAQ:BCRX surged briefly last week The company's only commercial product, Rapivab, was approved by the U.S. Food and Drug Administration in 0 to treat influenza infection.
Show less
Read more
Impact Snapshot
Event Time:
BCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCRX alerts
High impacting BioCryst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
BCRX
News
- BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory AgencyGlobeNewswire
- Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Brazil [Yahoo! Finance]Yahoo! Finance
- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.MarketBeat
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- BioCryst to Present at Upcoming Investor ConferencesGlobeNewswire
BCRX
Earnings
- 2/26/24 - Miss
BCRX
Sec Filings
- 4/2/24 - Form 4
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- BCRX's page on the SEC website